Skip to main navigation Skip to search Skip to main content

Substituted phenyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1

  • Wanying Sun
  • , Milana Maletic
  • , Steven S. Mundt
  • , Kashmira Shah
  • , Hratch Zokian
  • , Kathy Lyons
  • , Sherman T. Waddell
  • , James Balkovec
  • Merck

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Abstract

3-(Phenylcyclobutyl)-1,2,4-triazoles were identified as inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD1). They were shown to be active in the mouse in vivo pharmacodynamic model (PD) for HSD1 but exhibited a potent off-target activation of the Pregnane X Receptor (PXR). SAR studies and synthesis of analogs that led to the discovery of a selective HSD1 inhibitor are described in detail.

Original languageEnglish
Pages (from-to)2141-2145
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume21
Issue number7
DOIs
StatePublished - 1 Apr 2011

Keywords

  • 11β-Hydroxysteroid Dehydrogenase Type 1
  • Metabolic Syndrome
  • Pregnane X Receptor

Fingerprint

Dive into the research topics of 'Substituted phenyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1'. Together they form a unique fingerprint.

Cite this